Eczema, Lichenification, Prurigo and Erythroderma

Rook's Textbook of Dermatology: Eighth Edition

Volumn 1, Issue , 2010, Pages 954-1004

  Berth Jones, John ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

'dermatitis' and 'eczema' regarded as being synonymous; 'Metabolic' eczema and eczema associated with systemic disease; Chronic superficial scaly dermatitis; Eczema, lichenification, prurigo and erythroderma; Eczema, term derived from greek word meaning 'to boil'; Exudative discoid and lichenoid chronic dermatosis; Morphological types of hand eczema apron eczema, a type of hand eczema; Pellagra photosensitive dermatitis, a feature of pellagra; Post traumatic eczema; Seborrhoeic dermatitis

Indexed keywords

EID: 84888734070     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444317633.ch23     Document Type: Chapter

References (478)

1. Altekrueger I, Ackerman AB. 'Eczema' revisited. A status report based on current textbooks of dermatology. Am J Dermatopathol 1994; 16: 517-22.
2. Burton JL. Response of J.L. Burton. Am J Dermatopathol 1994; 16: 529-30.
3. MacKenzie-Wood AR, Freeman S. Unclassified endogenous eczema. Contact Dermatitis 1999; 41: 18-21.
4. Li LF, Liu G, Wang J. Prognosis of unclassified eczema. Arch Dermatol 2008; 144: 160-4.
5. Johnson M-LT, Roberts J. Prevalence of Dermatological Disease Among Persons 1-74 Years of Age. Washington DC: US Department of Health Education, National Center for Health Statistics, 1978: PHS 79-1660.
6. Meding B, Liden C, Berglind N. Self-diagnosed dermatitis in adults. Results from a population survey in Stockholm. Contact Dermatitis 2001; 45: 341-5.
7. Schafer T, Böhler S, Ruhdorfer S et al. Epidemiology of contact allergy in adults. Allergy 2001; 56: 1192-6.
8. Neame RL, Berth-Jones J, Kurinczuk JJ, Graham-Brown RAC. Prevalence of atopic dermatitis in Leicester: a study of methodology and examination of possible ethnic variation. Br J Dermatol 1995; 132: 772-7.
9. Horn R. The pattern of skin disease in general practice. Dermatol Pract 1986; Dec: 14-9.
10. Steele K. Primary dermatological care in general practice. J R Coll Gen Pract 1984; 34: 22-4.
11. Bowker NV, Cross KW, Fairburn EA et al. Sociological implications of an epidemiological study of eczema in the city of Birmingham. Br J Dermatol 1976; 95: 137-44.
12. Goh CL, Chua-Ty C, Koh SL. A descriptive profile of eczema in a tertiary referral centre in Singapore. Ann Acad Med Singapore 1993; 22: 307-15.
13. Meding B, Järvholm B. Hand eczema in Swedish adults-changes in prevalence between 1983 and 1996. J Invest Dermatol 2002; 118: 719-23.
14. Johnson MLT, Roberts R. Skin Conditions and Related Need for Medical Care Among Persons 1-74 Years of Age. Washington DC: US Department of Health Education, National Center for Health Statistics 1978; Series II, No. 212.
15. Baer RL, Rosenthal SA, Sims CF. The allergic eczema-like reaction and the primary irritant reaction. Arch Dermatol 1957; 76: 549-60.
16. Komura J, Ofuji S. Ultrastructural studies of allergic contact dermatitis in man. Arch Dermatol Res 1980; 267: 275-82.
17. Russell Jones R. The histogenesis of eczema. Clin Exp Dermatol 1983; 8: 213-25.
18. Russell Jones R, MacDonald DM. Eczema: immunopathogenesis and histogenesis. Am J Dermatopathol 1982; 4: 335-6.
19. Girolomoni G, Sebastiani S, Albanesi C, Cavani A. T-cell populations in the development of atopic and contact allergy. Curr Opin Immunol 2001; 13: 733-7.
20. Trautmann A, Akdis M, Kleeman D et al. T cell-mediated Fas-induced apoptosis plays a key pathogenic role in eczematous dermatitis. J Clin Invest 2000; 106: 25-35.
21. Berardesca E, Distante F. The modulation of skin irritation. Contact Dermatitis 1994; 31: 281-7.
22. Corsini E, Galli CL. Cytokines and irritant contact dermatitis. Toxicol Lett 1998; 102-103: 277-82.
23. Effendy I, Loffler H, Maibach HI. Epidermal cytokines in murine irritant responses. J Appl Toxicol 2000; 20: 335-41.
24. Smith HR, Basketter DA, McFadden JP. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol 2002; 27: 138-46.
25. Forslind B, Wahlberg JE. Assessment of chromium allergy; features of patch test reactions at electron microscopic resolution. Acta Derm Venereol (Stockh) 1977; 57: 29.
26. Lindberg M. Studies on the cellular and subcellular reactions in the epidermis of irritant and allergic dermatitis. Acta Derm Venereol (Stockh) 1982; 105 (Suppl.).
27. Calnan CD. Eczema for me. Trans St John's Hosp Dermatol Soc 1968; 54: 54-64.
28. Young AW. Dynamics of autosensitisation dermatitis. A clinical and microscopic concept of autoeczematisation. Arch Dermatol 1958; 77: 495-9.
29. Cunningham MJ, Zone JJ, Petersen MJ et al. Circulating activated (DR-positive) T lymphocytes in a patient with auto-eczematisation. J Am Acad Dermatol 1986; 13: 1039-41.
30. Kasteler JS, Peterson MJ, Vance JE, Zone JJ. Circulating activated T lymphocytes in autoeczematization. Arch Dermatol 1992; 128: 795-8.
31. Gonzalez-Amaro R, Baranda L, Abud-Mendoza C et al. Auto-eczematization is associated with abnormal immune recognition of autologous skin antigens. J Am Acad Dermatol 1993; 28: 56-60.
32. Fehr BS, Takashima A, Bergstresser PR, Cruz PD Jr. T cells reactive to keratinocyte antigens are generated during induction of contact hypersensitivity in mice. A model for autoeczematization in humans? Am J Contact Dermatitis 2000; 11: 145-54.
33. Horri I, Nakayama Y, Obata M et al. Stratum corneum hydration and amino-acid content in xerotic skin. Br J Dermatol 1989; 121: 587-92.
34. Tezuka T. Electron microscopic changes in xerosis senilis epidermis. Dermatologica 1983; 166: 59-61.
35. Onken HD, Moyer CA. The water barrier in human epidermis. Arch Dermatol 1963; 87: 584-90.
36. Anonymous. Winter skin. Lancet 1990; 335: 226.
37. Caplan RM. Superficial haemorrhagic fissures of the skin. Arch Dermatol 1970; 101: 442-51.
38. Warin AP. Eczéma craquelé as the presenting feature of myxoedema. Br J Dermatol 1973; 89: 289-91.
39. Weismann K, Wadskov S, Mikkelson HI. Acquired zinc deficiency dermatosis in man. Arch Dermatol 1978; 114: 1509-11.
40. Greist MC, Epinette WW. Cimetidine-induced xerosis and asteatotic dermatitis. Arch Dermatol 1982; 118: 253-4.
41. Björnberg J. Erythema craquelé provoked by corticosteroids on normal skin. Acta Derm Venereol (Stockh) 1982; 62: 147-51.
42. Barker DJ, Cotterill JA. Generalised eczéma craquelé as a presenting feature of lymphoma. Br J Dermatol 1977; 97: 323-6.
43. Van Voorst Vader PC, Folkers E, van Rhenen DJ. Craquelé-like eruption in angioimmunoblastic lymphadenopathy. Arch Dermatol 1979; 115: 370.
44. Greenwood R. Generalised eczéma craquelé as a presenting feature of adenocarcinoma. Br J Dermatol 1983; 109: 277-8.
45. Ridley CM. Eczéma craquelé and systemic carcinoma. Br J Dermatol 1984; 110: 246.
46. Calnan CD, Meara RH. Chronic superficial scaly dermatitis. Trans St John's Hosp Dermatol Soc 1956; 37: 12-3.
47. Haeffner AC, Smoller BR, Zepter K, Wood GS. Differentiation and clonality of lesional lymphocytes in small plaque parapsoriasis. Arch Dermatol 1995; 131: 321-4.
48. Burg G, Dummer R. Small plaque (digitate) parapsoriasis is an 'abortive cutaneous T-cell lymphoma' and is not mycosis fungoides. Arch Dermatol 1995; 131: 336-8.
49. Ackerman AB. If small plaque (digitate) parapsoriasis is a cutaneous T-cell lymphoma, even an 'abortive' one, it must be mycosis fungoides. Arch Dermatol 1996; 132: 562-6.
50. Hu CH, Winklemann RK. Digitate dermatosis. A new look at symmetrical small plaque parapsoriasis. Arch Dermatol 1973; 107: 65-9.
51. Lambert WE, Everett MA. The nosology of parapsoriasis. J Am Acad Dermatol 1981; 5: 731-45.
52. Samman PD. The natural history of parapsoriasis en plaques (chronic superficial dermatitis) and prereticulotic poikiloderma. Br J Dermatol 1972; 87: 405-11.
53. Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311 nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 1999; 135: 1377-80.
54. Jillson OF. Dermatophytids and candidids. Semin Dermatol 1983; 2: 60.
55. Kaaman T, Torssander J. Dermatophytide-a misdiagnosed entity. Acta Derm Venereol (Stockh) 1983; 63: 404-8.
56. Peck SM. Fungus antigens and their importance as sensitizers in the general population. Ann NY Acad Sci 1950; 50: 1362-75.
57. Veien NK, Hattel T, Laurberg G. Plantar Trichophyton rubrum infections may cause dermatophytids on the hands. Acta Derm Venereol (Stockh) 1994; 74: 403-4.
58. Bendl BJ. Nummular eczema of stasis origin: a morphological pattern of diverse etiology. Int J Dermatol 1979; 18: 129-35.
59. Shelley WB, ed. Consultations in Dermatology, Vol II. Philadelphia: WB Saunders, 1974; 172-5.
60. Carr R, Berke M, Becker SW. Incidence of atopy in patients with various neurodermatoses. Arch Dermatol 1964; 89: 20-6.
61. Hellgren L, Mobacken H. Nummular eczema. Clinical and statistical data. Acta Derm Venereol (Stockh) 1969; 49: 189-96.
62. Kreuger GG. IgE levels in nummular eczema and ichthyosis. Arch Dermatol 1973; 107: 56-8.
63. Leyden JJ, Kligman AM. The case for steroid-antibiotic combinations. Br J Dermatol 1977; 96: 179-87.
64. Wachs GN, Maibach H. Co-operative double blind trial of an antibioticcorticoid combination in impetiginized atopic dermatitis. Br J Dermatol 1976; 95: 323-8.
65. Parish WE, Welbourn E, Champion RH. Hypersensitivity to bacteria in eczema. IV: Cytotoxic effect of antibacterial antibody on skin cells acquiring bacterial antigens. Br J Dermatol 1976; 95: 493-500.
66. Fleming C, Parry E, Forsyth A, Kemmett D. Patch testing in discoid eczema. Contact Dermatitis 1997; 36: 261-4.
67. Khurana S, Jain VK, Aggarwal K, Gupta S. Patch testing in discoid eczema. J Dermatol 2002; 29: 763-7.
68. Rollins TG. From xerosis to nummular dermatitis. JAMA 1968; 206: 637.
69. Aoyama H, Tanaka M, Hara M et al. Nummular eczema: an addition of senile xerosis and unique cutaneous reactivities to enviromental aeroallergens. Dermatology 1999; 199: 135-9.
70. Higgins EM, DuVivier AW. Cutaneous disease and alcohol misuse. Br Med Bull 1994; 50: 85-98.
71. Morrow DM, Rapaport MJ, Strick RA. Hypersensitivity to aloe. Arch Dermatol 1980; 116: 1064-5.
72. Le Coz CJ. Contact nummular (discoid) eczema from depilating cream. Contact Dermatitis 2002; 42: 111-2.
73. Adachi A, Horikawa T, Takashima T, Ichihashi M. Mercury-induced nummular dermatitis. J Am Acad Dermatol 2000; 43: 383-5.
74. Church R. Eczema provoked by methyldopa. Br J Dermatol 1974; 91: 373-8.
75. Wilkinson SM, Smith AG, Davis MJ et al. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Ann Rheum Dis 1992; 51: 881-4.
76. Hambly EM, Wilkinson DS. Sur quelques formes atypiques d'eczéma chez l'enfant. Ann Dermatol Vénéréol 1978; 105: 369-71.
77. Ackerman AB, ed. Histologic Diagnosis of Inflammatory Skin Diseases. Philadelphia: Lea & Febiger, 1978: 499-506.
78. Elder D, ed. Lever's Histopathology of the Skin, 8th edn. Philadelphia: Lippincott, 1997: 209-16.
79. Cowan MA. Nummular eczema-a review, follow-up and analysis of 325 cases. Acta Derm Venereol (Stockh) 1961; 41: 453-60.
80. Calnan CD, Meara RH. Discoid eczema-dry type. Trans St John's Hosp Dermatol Soc 1956; 37: 26-8.
81. Ozkaya-Bayazit E, Gungor H. Carbamazepine induced eczematous eruption-clinically resembling atopic dermatitis. J Eur Acad Dermatol Venereol 1999; 12: 182-3.
82. Whittam LR, Hay RJ, Highes RAC. Eczematous reactions to human immune globulin. Br J Dermatol 1997; 137: 481-2.
83. Guin JD. Eyelid dermatitis: a report of 215 patients. Contact Dermatitis 2004; 50: 87-90.
84. Amin KA, Belsito DV. The aetiology of eyelid dermatitis: a 10-year retrospective analysis. Contact Dermatitis 2006; 55: 280-5.
85. Guin JD. Clinical presentations of patients sensitive to natural rubber latex. Dermatitis 2004; 15: 192-6.
86. Dewachter P, Mouton-Faivre C. Anaesthetists should be aware of delayed hypersensitivity to phenylephrine. Acta Anaesthesiol Scand 2007; 51: 637-9.
87. Sulzberger MB, Garbe W. Nine cases of distinctive exudative discoid and lichenoid chronic dermatosis. Arch Dermatol Syphilol 1937; 36: 247-72.
88. Sulzberger MB. Distinctive exudative discoid and lichenoid chronic dermatosis (Sulzberger and Garbe) re-examined-1978. Br J Dermatol 1979; 100: 13-20.
89. Rongioletti F, Corbella L, Rebora A. Exudative discoid and lichenoid chronic dermatosis (Sulzberger-Garbe). A fictional disease? Int J Dermatol 1989; 28: 40-3.
90. Trueb RM. Exudative discoid and lichenoid chronic dermatosis (Sulzberger-Garbe): presentation with a puzzling penile plaque. Report of two cases of Sulzberger-Garbe dermatosis with typical penile lesions. J Eur Acad Dermatol Venereol 1994; 3: 411-7.
91. Freeman K, Hewitt M, Warin AP. Two cases of distinctive exudative discoid and lichenoid chronic dermatosis of Sulzberger and Garbe responding to azathioprine. Br J Dermatol 1984; 111: 215-20.
92. Meyerson LB. A peculiar papulosquamous eruption involving pigmented naevi. Arch Dermatol 1971; 103: 510-2.
93. Brenan J, Kossard S, Krivanek J. Halo eczema around melanocytic naevi. Int J Dermatol 1985; 24: 226-9.
94. Nicholls DSH, Mason GH. Halo dermatitis around a melanocytic naevus: Meyerson's naevus. Br J Dermatol 1988; 118: 125-9.
95. Weedon D, Farnsworth J. Spongiotic changes in melanocytic naevi. Am J Dermatopathol 1984; 6: 257-9.
96. Krischer J, Pechere M, Salomon D et al. Interferon alfa-2b-induced Meyerson's nevi in a patient with dysplastic nevus syndrome. J Am Acad Dermatol 1999; 40: 105-6.
97. Ramon R, Silvestre JF, Betlloch I et al. Progression of Meyerson's naevus to Sutton's naevus. Dermatology 2000; 200: 337-8.
98. Rosen R, Paver K, Kossard S. Halo eczema surrounding seborrheic keratosis: an example of perilesional dermatitis. Australas J Dermatol 1990; 31: 73-6.
99. Gallais V, Lacour JP, Perrin C et al. Halo eczema around a histiocytofibroma: the Meyerson phenomenon. Ann Dermatol Venereol 1993; 120: 617-20.
100. Menné T, Maibach HI. Hand Eczema, 2nd edn. Boca Raton: CRC Press, 2000.
101. Smith HR, Armstrong DK, Wakelin SH et al. Descriptive epidemiology of hand dermatitis at the St John's contact dermatitis clinic 1983-97. Br J Dermatol 2000; 142: 284-7.
102. Uter W, Gefeller O, Schwanitz HJ. An epidemiological study of the influence of season (cold and dry air) on the occurrence of irritant skin changes of the hands. Br J Dermatol 1998; 138: 266-72.
103. Miller RM, Coger RW. Skin conductance conditioning with dyshidrotic eczema patients. Br J Dermatol 1979; 101: 435-40.
104. Meding B, Swanbeck G. Epidemiology of different types of hand eczema in an industrial city. Acta Derm Venereol (Stockh) 1989; 69: 227-33.
105. Duarte I, Terumi Nakano J, Lazzarini R. Hand eczema: evaluation of 250 patients. Am J Contact Dermatitis 1998; 9: 216-23.
106. Lonnroth E, Shahnavaz H. Atopic dermatitis, conjunctivitis, and hand dermatitis among Swedish dental personnel, including use of personal protective devices. Swed Dent J 1998; 22: 105-15.
107. Funke U, Fartasch M, Diepgen TL. Incidence of work-related hand eczema during apprenticeship: first results of a prospective cohort study in the car industry. Contact Dermatitis 2001; 44: 166-72.
108. Uter W, Pfahlberg A, Gefeller O, Schwanitz HJ. Hand dermatitis in a prospectively-followed cohort of hairdressing apprentices: final results of the POSH study. Prevention of occupational skin disease in hairdressers. Contact Dermatitis 1999; 41: 280-6.
109. Hjorth N, Roed Petersen J. Occupational protein contact dermatitis in food handlers. Contact Dermatitis 1976; 2: 28-42.
110. Hamann C P. Natural rubber latex protein sensitivity: a review. Am J Contact Dermatitis 1993; 4: 4-21.
111. Sinha A, Harrison PV. Latex glove allergy among hospital employees: a study in the north-west of England. Occup Med (Oxf) 1998; 48: 405-10.
112. Christensen OB, Möller H. External and internal exposure to the antigen in the hand eczema of nickel allergy. Contact Dermatitis 1975; 1: 136-41.
113. Cronin E. Oral challenge in nickel hypersensitive women with hand eczema. In: Brown SS, Sundermann FW, eds. Nickel Toxicology. New York: Academic Press, 1980: 149-55.
114. Kaaber K, Veien NK. Chromate ingestion in chronic dermatitis. Contact Dermatitis 1978; 4: 119-20.
115. Menné T, Hjorth N. Reactions from systemic exposure to contact allergens. Semin Dermatol 1982; 1: 15-24.
116. Cronin E. Clinical patterns of hand eczema in women. Contact Dermatitis 1985; 13: 153-61.
117. Winkelman RK, Gleich GJ. Chronic acral dermatitis-association with extreme elevations of IgE. JAMA 1973; 225: 378-81.
118. Gette MT, Marks JE. Tulip fingers. Arch Dermatol 1990; 126: 203-5.
119. Guin JD, Franks H. Finger tip dermatitis in a retail florist. Cutis 2001; 67: 328-30.
120. Bleumink KE. Contact dermatitis to garlic. Arch Dermatol Forsch 1973; 247: 117-24.
121. Hjorth N. Gut eczema in slaughterhouse workers. Contact Dermatitis 1978; 4: 49-52.
122. Goransson K. Occupational contact urticaria to fresh cow and pig blood in slaughtermen. Contact Dermatitis 1982; 7: 281-2.
123. Hersle K, Mobacken H. Hyperkeratotic dermatitis of the palms. Br J Dermatol 1982; 107: 195-202.
124. Schwanitz HJ, ed. Atopic Palmoplantar Eczema. Berlin: Springer-Verlag, 1988.
125. Mobacken H, Rosen K, Swanbeck G. Oral psoralen photochemotherapy (PUVA) of hyperkeratotic dermatitis of the palms. Br J Dermatol 1983; 109: 205-8.
126. Ruzicka T, Lynde CW, Jemec GBE et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808-17.
127. Menné T, Maibach HI. Hand Eczema, 2nd edn. Boca Raton: CRC Press, 2000: 165-8.
128. Agrup G. Hand eczema and other dermatoses in southern Sweden. Acta Derm Venereol (Stockh) 1969; 49 (Suppl. 61).
129. Meding B, Swanbeck G. Epidemiology of different types of hand eczema in an industrial city. Acta Derm Venereol (Stockh) 1989; 69: 227-33.
130. Lorincz AL, Grauer FH. Simultaneous dyshidrosis in monozygotic twins during their separation. Arch Dermatol 1956; 74: 245-52.
131. Menné T, Holm NV. Nickel allergy in a female twin population. Int J Dermatol 1983; 22: 22-8.
132. Hofbauer GF, Nestle FO. Irritant contact dermatitis of the hands following thoracic sympathectomy. Contact Dermatitis 2000; 42: 119-20.
133. Chowdrey MM, Hedges R, Lanigan SW. Unilateral resolution of palmar eczema and hyperhidrosis complicated by Horner's syndrome following ipsilateral endoscopic cervical sympathectomy. Br J Dermatol 2000; 143: 653-4.
134. Simons RDGP, ed. Eczema of the Hands, 2nd edn. Basel: Karger, 1966.
135. Miller RM, Coger RW. Skin conductance conditioning with dyshidrotic eczema patients. Br J Dermatol 1979; 101: 435-40.
136. Schwanitz HJ, ed. Atopic Palmoplantar Eczema. Berlin: Springer-Verlag, 1988.
137. Oddoze L, Témime P. Dyshidrosis and atopy. Bull Soc Fr Dermatol Syphiligr 1968; 75: 378.
138. Lodi A, Betti R, Chianelli G et al. Epidemiological, clinical and allergological observations on pompholyx. Contact Dermatitis 1992; 26: 17-21.
139. de Boer EM, Bruynzeel DP, Van Ketel WG. Dyshidrotic eczema as an occupational dermatitis in metal workers. Contact Dermatitis 1988; 19: 184-8.
140. Edman B. Palmar eczema: a pathogenic role for acetylsalicylic acid, contraceptives and smoking? Acta Derm Venereol (Stockh) 1988; 68: 402-7.
141. Lehucher-Michel MP, Koeppel MC, Lanteaume A, Sayag J. Dyshidrotic eczema and occupation: a descriptive study. Contact Dermatitis 2000; 43: 200-5.
142. Meneghini CL, Angelini G. Contact and microbial allergy in pompholyx. Contact Dermatitis 1974; 5: 46.
143. Menné T, Hjorth N. Pompholyx-dyshidrotic eczema. Semin Dermatol 1983; 2: 75-80.
144. Christensen OB, Möller H. Nickel allergy and hand eczema. Contact Dermatitis 1975; 1: 129-35.
145. Christensen OB, Möller H. External and internal exposure to antigen in hand eczema of nickel allergy. Contact Dermatitis 1975; 1: 136-42.
146. Cronin E. Oral challenge in nickel hypersensitive women with hand eczema. In: Brown SS, Sunderman FW Jr, eds. Nickel Toxicology. New York: Academic Press, 1980: 149-55.
147. Kaaber K, Veien NK, Tjell JC. Low nickel diet in the treatment of patients with chronic nickel dermatitis. Br J Dermatol 1978; 98: 197-201.
148. Burrows D, Creswell S, Merrett JD. Nickel, hands and hip prostheses. Br J Dermatol 1981; 105: 437-44.
149. Jordan WP, King SE. Nickel feeding in nickel-sensitive patients with hand eczema. J Am Acad Dermatol 1979; 1: 506-8.
150. Kaaber K, Veien NK. Antabuse treatment of nickel dermatitis: chelation-a new principle in the treatment of nickel dermatitis. Contact Dermatitis 1979; 5: 221-8.
151. Ekelund AG, Möller H. Oral provocation in eczematous contact allergy to neomycin and hydroxyquinolones. Acta Derm Venereol (Stockh) 1969; 49: 422-6.
152. Tagami H, Watanabe S, Ofuji S. Trichophyton contact sensitivity in patients with dermatophytosis. Arch Dermatol 1977; 113: 1409-14.
153. Uehara M. Pustulosis palmaris et plantaris. Evolutionary sequence from vesicular to pustular lesions. Semin Dermatol 1983; 2: 51-6.
154. Barth JH, Venning VA, Wojnarowska F. Palmoplantar involvement in autoimmune blistering disorders: pemphigoid, linear IgA disease, and herpes gestationis. Clin Exp Dermatol 1988; 13: 85-6.
155. Duhra P, Ryatt KS. Haemorrhagic pompholyx in bullous pemphigoid. Clin Exp Dermatol 1988; 13: 342-3.
156. Egan CA, Rallis TM, Meadows KP, Krueger GG. Low dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 1999; 40: 612-4.
157. Stambaugh MD, DeNittis AS, Wallner PE, Heymann WR. Complete remission of refractory dyshidrotic eczema with the use of radiation therapy. Cutis 2000; 65: 211-4.
158. Cordoba S, Sanchez-Perez J, Garcia-Diez A. Ring dermatitis as a clinical presentation of fragrance sensitization. Contact Dermatitis 2000; 42: 242.
159. Gerwig T, Winer MN. Radioactive jewelry as a cause of cutaneous tumor. JAMA 1968; 205: 595-6.
160. Lim KB, Tan T, Rajan VS. Dermatitis palmaris sicca-a distinctive pattern of hand dermatitis. Clin Exp Dermatol 1986; 11: 553-9.
161. Maibach HI, Epstein E. Eczematous psoriasis. Semin Dermatol 1983; 2: 45-50.
162. Fregert S, Hjorth N. Epidemiology of contact dermatitis. Trans St John's Hosp Dermatol Soc 1969; 55: 17-35.
163. Menné T, Holm NV. Nickel allergy and hand dermatitis in a stratified sample of the Danish female population. Acta Derm Venereol (Stockh) 1982; 62: 35-41.
164. Wilkinson DS. The role of contact allergy in hand eczema. Trans St John's Hosp Dermatol Soc 1970; 56: 19-21.
165. Wilkinson DS. Contact dermatitis of the hands. Trans St John's Hosp Dermatol Soc 1972; 58: 163-72.
166. Schwanitz HJ, Uter W. Interdigital dermatitis: sentinel skin damage in hair dressers. Br J Dermatol 2000; 142: 1011-2.
167. Malten KE. Thoughts on irritant contact dermatitis. Contact Dermatitis 1981; 7: 238-47.
168. Lammintausta K, Kalimo K. Atopy and hand dermatitis in hospital wet work. Contact Dermatitis 1981; 7: 301.
169. Meding B, Swanbeck G. Epidemiology of different types of hand eczema in an industrial city. Acta Derm Venereol (Stockh) 1989; 69: 227-33.
170. Agrup G. Hand eczema and other hand dermatoses in South Sweden. Acta Derm Venereol (Stockh) 1969; 49 (Suppl. 61).
171. Keczkes K, Bhate SM, Wyatt EH. The outcome of primary hand dermatitis. Br J Dermatol 1983; 109: 665-9.
172. Epstein E. Hand dermatitis: practical management and current concepts. J Am Acad Dermatol 1984; 10: 395-424.
173. Uehara M, Takada K. Use of soap in the management of atopic dermatitis. Clin Exp Dermatol 1985; 10: 419-25.
174. McCormick RD, Buchman TL, Maki DG. Double-blind, randomised trial of scheduled use of a novel barrier cream and an oil-containing lotion for the protection of the hands of health care workers. Am J Infection Control 2000; 28: 302-10.
175. Fowler JF Jr. A skin moisturising cream containing Quaternium-18-Bentonite effectively improves chronic hand dermatitis. J Cutan Med Surg 2001; 5: 201-5.
176. Wigger-Alberti W, Maraffio B, Wernli M, Elsner P. Self-application of a protective cream. Pitfalls of occupational skin protection. Arch Dermatol 1997; 133: 861-4.
177. Wigger-Alberti W, Elsner P. Do barrier creams and gloves prevent or provoke contact dermatitis. Am J Contact Dermatitis 1998; 9: 100-6.
178. Mourisden HIT, Faber O. Penetration of protective gloves by allergens and irritants. Trans St John's Hosp Dermatol Soc 1973; 57: 230.
179. Nilsson E. Density of the microflora in hand eczema before and after topical treatment with a potent corticosteroid. J Am Acad Dermatol 1986; 15: 192-7.
180. Veien NK, Olholm Larsen P, Thestrup-Pederson K, Schou G. Long term intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 1999; 140: 882-6.
181. Schnopp C, Remling R, Mohrenschlager M et al. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol 2002; 46: 73-7.
182. Hersle K, Mobacken H. Hyperkeratotic dermatitis of the palms. Br J Dermatol 1982; 107: 145-202.
183. Baden HP. Treatment of hyperkeratotic dermatitis of the palms. Sequential treatment with a keratolytic gel and corticosteroid ointment. Arch Dermatol 1974; 110: 737-8.
184. Bruynzeel DP. Oral psoralen photochemotherapy of allergic contact dermatitis of the hands. Dermatosen 1982; 30: 16-20.
185. Le Vine MJ, Parrish JA, Fitzpatrick TB. Oral methoxalen photochemotherapy (PUVA) of dyshidrotic eczema. Acta Derm Venereol (Stockh) 1981; 61: 570-1.
186. Mobacken H, Rosen K, Swanbeck G. Oral psoralen photochemotherapy (PUVA) of hyperkeratotic dermatitis of the palms. Br J Dermatol 1983; 109: 205-8.
187. Morison WL, Parish JA, Fitzpatrick TB. Oral methoxalen photochemotherapy of recalcitrant dermatoses of the palms and soles. Br J Dermatol 1978; 99: 297-302.
188. Mork N-J, Austad J. Short wave ultraviolet light (UVB) treatment of allergic contact dermatitis of the hands. Acta Derm Venereol (Stockh) 1983; 63: 87-9.
189. Rosen K, Mobacken H, Swanbeck G. Chronic eczematous dermatitis of the hands; a comparison of PUVA and UVB treatment. Acta Derm Venereol (Stockh) 1987; 67: 48-54.
190. Tegner E. PUVA treatment of chronic eczematous dermatitis of the palms and soles. Acta Derm Venereol (Stockh) 1985; 65: 451-3.
191. Taylor CR, Baron ED. Hand and foot PUVA soaks: an audit of the Massachusetts General Hospital's experience from 1994 to 1998. Photodermatol Photoimmunol Photomed 1999; 15: 188-92.
192. Grundmann-Kollmann M, Behrens S, Peter RU, Kerscher M. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed 1999; 15: 87-9.
193. Fairris GM, Jones DH, Mack PD et al. Conventional superficial X-ray versus Grenz ray therapy in the treatment of constitutional eczema of the hands. Br J Dermatol 1985; 112: 339-41.
194. Ruzicka T, Lynde CW, Jemec GBE et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multi-centre trial. Br J Dermatol 2008; 158: 808-17.
195. Reymann F. Two years experience with Tigason treatment of pustulosis palmoplantaris and eczema keratoticum manuum. Dermatologica 1982; 164: 209-16.
196. Peterson CS, Menné T. Cyclosporin A responsive chronic vesicular hand eczema. Acta Derm Venereol (Stockh) 1992; 72: 436-7.
197. Granlund H, Erkko P, Reitamo S. Comparison of the influence of cyclosporine and topical betamethasone-17, 21-dipropionate treatment on quality of life in chronic hand eczema. Act Derm Venereol (Stockh) 1997; 77: 54-8.
198. Veien NK, Kaaber K, Larsen PO et al. Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind placebo-controlled trial. J Am Acad Dermatol 1995; 32: 1056-7.
199. Proske S, Uter W, Schwanitz HJ. Lymphedema of the hand following recurrent erysipelas secondary to fissured irritant contact dermatitis. Contact Dermatitis 2000; 42: 368-9.
200. Christensen OB, Möller H. External and internal exposure to the antigen in the hand eczema of nickel allergy. Contact Dermatitis 1975; 1: 136-41.
201. Christensen OB, Kristensen M. Treatment with disulfiram in chronic nickel hand dermatitis. Contact Dermatitis 1982; 8: 59-63.
202. Nilsson E, Henning C, Hjoreitsson M-L. Density of the microflora in hand eczema before and after topical treatment with a potent corticosteroid. J Am Acad Dermatol 1986; 15: 192-7.
203. Goodfield M. C-reactive protein levels in venous ulceration: an indication of infection? J Am Acad Dermatol 1988; 18: 1048-52.
204. Parish WE, Welbourn E, Champion RH. Hypersensitivity to bacteria in eczema. Titre and immunoglobulin class of antibodies to staphylococci and micrococci. Br J Dermatol 1976; 95: 285-93.
205. Parish WE, Welbourn E, Champion RH. Hypersensitivity to bacteria in eczema. IV: cytotoxic effect of antibacterial antibody on skin cells acquiring bacterial antigens. Br J Dermatol 1976; 95: 493-506.
206. Welbourn E, Champion RH, Parish WE. Hypersensitivity to bacteria in generalized eczema. I: bacterial culture, skin tests, and immunofluorescent detection of immunoglobulins and bacterial antigens. Br J Dermatol 1976; 94: 619-25.
207. Welbourn E, Champion RH, Parish WE. Hypersensitivity to bacteria in eczema. III: Arthus-like responses in bacterial antigens in the absence of specific antibody. Br J Dermatol 1976; 95: 379-87.
208. Skov L, Olsen JV, Giornd R et al. Application of Staphylococcal enterotoxin B on normal and atopic skin induces upregulation of T cells by a superantigenmediated mechanism. J Allergy Clin Immunol 2000; 105: 820-6.
209. Rockl H. Mikrobiele Genese von Ekzemen. Hautarzt 1964; 15: 398-9.
210. Weismann K, Hjorth N. Microbial eczema of the feet. Br J Dermatol 1982; 107: 330-7.
211. Leyden JJ, Kligman AM. Interdigital athlete's foot. The interaction of dermatophytes and resident bacteria. Arch Dermatol 1978; 114: 1466-9.
212. Sweet RD. A pattern of eczema in Jamaica. Br J Dermatol 1966; 78: 93-100.
213. Walshe M. Infective dermatitis in Jamaican children. Br J Dermatol 1967; 79: 229-36.
214. LaGrenade L, Hanchard B, Fletcher V et al. Infective dermatitis of Jamaican children: a marker for HTLV-1 infection. Lancet 1990; 336: 1345-7.
215. Hanchard B, LaGrenade L, Carberry C et al. Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years. Lancet 1991; 338: 1593-4.
216. LaGrenade L. HTLV-1, infective dermatitis, and tropical spastic paraparesis. Mol Neurobiol 1994; 8: 147-53.
217. LaGrenade L, Manns A, Fletcher V et al. Clinical pathologic and immunologic features of human T-lymphotrophic virus type-1 associated infective dermatitis in children. Arch Dermatol 1998; 134: 439-44.
218. Ashton RE, Griffiths WA. Juvenile plantar dermatosis-atopy or footwear? Clin Exp Dermatol 1986; 11: 529-34.
219. Mackie RM. Juvenile plantar dermatosis. Semin Dermatol 1982; 1: 67-75.
220. Shrank AB. Aetiology of juvenile plantar dermatosis. Br J Dermatol 1979; 100: 641-6.
221. Young E. Forefoot eczema-further studies and a review. Clin Exp Dermatol 1986; 11: 523-8.
222. Schultz H, Zachariae H. The Trafuril test in recurrent juvenile eczema of hands and feet. Acta Derm Venereol (Stockh) 1972; 52: 398-400.
223. Graham RM, Verbov JL, Vickers CFH. Juvenile plantar dermatosis. Clin Exp Dermatol 1987; 12: 468.
224. Stankler L. Juvenile plantar dermatosis in identical twins. Br J Dermatol 1978; 99: 585-6.
225. Neering H, Van Dijk E. Juvenile plantar dermatosis. Acta Derm Venereol (Stockh) 1978; 58: 531.
226. Lim KB, Tan T, Rajan VS. Dermatitis palmaris sicca-a distinctive pattern of hand eczema. Clin Exp Dermatol 1986; 11: 553-9.
227. Jones SK, English JSC, Forsyth A et al. Juvenile plantar dermatosis-an eight year follow-up of 102 patients. Clin Exp Dermatol 1987; 12: 5-7.
228. Kint A. Dermatitis plantaris sicca. Dermatologica 1982; 165: 500-9.
229. Millard LG, Gould DG. Juvenile plantar dermatosis. Clin Exp Dermatol 1977; 2: 186-7.
230. Möller H. Atopic winter feet in children. Acta Derm Venereol (Stockh) 1972; 52: 401-5.
231. Shuster S, Marks J. Dermatogenic enteropathy. A new cause of steatorrhoea. Lancet 1965; i: 1367-8.
232. Wells GC. Skin disorders in relation to malabsorption. BMJ 1962; ii: 937-43.
233. Marks J, Shuster S. Small intestinal mucosal abnormalities in various skin diseases-fact or fancy. Gut 1970; 11: 281.
234. Cooke WT, Peeney ALP, Hawkins CF. Symptoms, signs and diagnostic features of idiopathic steatorrhoea. QJM 1953; 22 (New series): 59-79.
235. Badenoch DM. Steatorrhoea in the adult. BMJ 1960; ii: 879-87.
236. Dent CE, Garretts M. Skin changes in hypocalcaemia. Lancet 1960; i: 142.
237. Grimbacher B, Peters T, Peter HH. Lactose-intolerance may induce severe chronic eczema. Int Arch Allergy Immunol 1997; 113: 516-8.
238. Peterson RDA, Page AR, Good RA. Wheal and erythema allergy in patients with agammaglobulinaemia. J Allergy 1962; 33: 406-11.
239. Webster AD, Wood CBS. Skin diseases in immunodeficiency. In: Verbov J, ed. Modern Topics in Paediatric Dermatology. London: Heinemann, 1979: 179-200.
240. Jung LKL, Kapoor N, Englehard D et al. Pyoderma, eczema and folliculitis, with defective leucocyte and lymphocyte function. Lancet 1983; ii: 185-7.
241. Armstrong MD. Further observations on the effect of phenylalanine-restricted diet on patients with phenylketonuria. Am J Clin Nutr 1957; 5: 543-54.
242. Kang ES, Kennedy JL, Gates L et al. Clinical observations in phenylketonuria. Pediatrics 1965; 35: 932-43.
243. Tourian A. In: Stanbury J et al., eds. Metabolic Basis of Inherited Disease, 5th edn. New York: McGraw-Hill, 1983: 279.
244. O'Farrell N. Pityriasis alba. Arch Dermatol 1956; 73: 376-7.
245. Wells BT, Whyte BT, Kierland R. Pityriasis alba. A ten-year survey and review of the literature. Arch Dermatol 1960; 82: 183-9.
246. Zaynoun ST, Aftimos BG, Tenekjian KK. Extensive pityriasis alba: a histological, histochemical and ultrastructural study. Br J Dermatol 1983; 108: 83-90.
247. Vargos-Ocampo F. Pityriasis alba: a histologic study. Int J Dermatol 1993; 32: 870-3.
248. In S-I, Yi SW, Kang HY et al. Clinical and histopathologic characteristics of pityriasis alba. Clin Exp Dermatol 2009: in press.
249. Adamson HG. On a form of chronic superficial dermatitis in circumscribed patches with symmetrical distribution occurring in children. Br J Dermatol 1908; 120: 109-22.
250. Bassaly M, Miale A, Prasad AS. Studies on pityriasis alba. Arch Dermatol 1963; 88: 272-3.
251. Kim SK, Kang HY, Lee ES et al. Clinical and histopathologic characteristics of nevus depigmentosus. J Am Acad Dermatol 2006; 55: 423-8.
252. Whitmore SE, Simmons-O'Brien E, Rotter FS. Hypopigmented mycosis fungoides. Arch Dermatol 1994; 130: 476-80.
253. Fujita WH, McCormick CL, Parneix-Spake A. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Int J Dermatol 2007; 46: 700-5.
254. Mathias CG. Post-traumatic eczema. Dermatol Clin 1988; 6: 35-42.
255. Carr RD, Rau RC. Dermatitis at vein graft site in coronary artery bypass patients. Arch Dermatol 1981; 117: 814-5.
256. Bart RS. Dermatitis at vein graft site. Arch Dermatol 1983; 119: 97.
257. Hruza LL, Hruza GJ. Saphenous vein graft donor site dermatitis: case reports and literature review. Arch Dermatol 1993; 129: 609-12.
258. Johnson M-LT, Roberts J. Prevalence of Dermatological Diseases Among Persons 1-74 Years of Age. Washington DC: US Department of Health Education, National Center for Health Statistics, 1978: PHS 79-1660.
259. Berger RS. Cutaneous manifestations of early human immunodeficiency virus exposure. J Am Acad Dermatol 1988; 19: 298-303.
260. Shuster S. The aetiology of dandruff and mode of action of therapeutic agents. Br J Dermatol 1984; 111: 235-42.
261. Hay RJ, Graham-Brown RA. Dandruff and seborrhoeic dermatitis: causes and management. Clin Exp Dermatol 1997; 22: 3-6.
262. Pechere M, Krischer J, Remondat C et al. Malassezia species carriage in patients with seborrhoeic dermatitis. J Dermatol 1999; 26: 558-61.
263. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000; 38: 337-41.
264. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff and seborrhoeic dermatitis. J Invest Dermatol 1975; 64: 401.
265. Shuster S, Blatchford N. Seborrhoeic dermatitis and dandruff-a fungal disease. Royal Soc Med Services 1988; Series 132: 1-54.
266. Bergbrant IM, Andersson B, Faergemann J. Cell-mediated immunity to Malassezia furfur in patients with seborrhoeic dermatitis and pityriasis versicolor. Clin Exp Dermatol 1999; 24: 402-6.
267. Parry ME, Sharpe GR. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol 1998; 139: 254-63.
268. Rosenberg EW. Effect of topical applications of heavy suspensions of killed Malassezia ovalis on rabbit skin. Mycopathologia 1980; 72: 147-52.
269. Faergemann J, Bergbrant IM, Dohse M et al. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001; 144: 549-56.
270. Burton JL, Pye RJ. Seborrhoea is not a feature of seborrhoeic dermatitis. BMJ 1983; 286: 1169-71.
271. Burton JL, Cartilidge M, Shuster S. Effect of l-dopa on the seborrhoea of Parkinsonism. Br J Dermatol 1973; 88: 475-9.
272. Parish LC. l-dopa for seborrhoeic dermatitis. N Engl J Med 1970; 283: 879.
273. Bettley FR, Marten RH. Unilateral seborrhoeic dermatitis following a nerve lesion. Arch Dermatol 1956; 73: 110-5.
274. Wilson CL, Walshe M. Incidence of seborrhoeic dermatitis in spinal injury patients. Br J Dermatol 1988; 119: 48S.
275. Cowley NC, Farr PM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol 1990; 122: 71-6.
276. Hodgson-Jones IS, McKenna RMB, Wheatley VR. The surface skin fat in seborrhoeic dermatitis. Br J Dermatol 1953; 65: 246-51.
277. Pye RJ, Meyrick G, Burton JL. Skin surface lipids in seborrhoeic dermatitis. Br J Dermatol 1977; 97 (Suppl. 15): 12.
278. Alessi E, Cusini M, Zerboni R. Mucocutaneous manifestations of patients infected with AIDS. J Am Acad Dermatol 1988; 19: 290-7.
279. Smith KJ, Skelton HG, Yeager J et al. Cutaneous findings in HIV-1 positive patients: a 42-month prospective study. J Am Acad Dermatol 1994; 31: 746-54.
280. Moehrle M, Dennenmoser B, Schlagenhauff B et al. High prevalence of seborrhoeic dermatitis on the face and scalp in mountain guides. Dermatology 2000; 201: 146-7.
281. Tager A. Seborrhoeic dermatitis in acute cardiac disease. Br J Dermatol 1964; 76: 367-9.
282. Barba A, Piubello W, Vantini I et al. Skin lesions in chronic alcoholic pancreatitis. Dermatologica 1982; 164: 322-6.
283. Tegner E. Seborrhoeic dermatitis of the face induced by PUVA treatment. Acta Derm Venereol (Stockh) 1983; 63: 335-9.
284. Pinkus H, Mehregan AM. The squirting papilla. J Invest Dermatol 1966; 49: 109-15.
285. Kligman AM. Dandruff, its causes and treatment. In: Orfanos C, ed. Haar und Haarkrankheiten. Stuttgart: Fischer, 1979: 663-9.
286. Groisser D, Bottone EJ, Lebwohl M. Association of Pityrosporum orbiculare (Malassezia furfur) with seborrhoeic dermatitis in patients with acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 1989; 20: 770-3.
287. Armstrong DK, Smith HR, Rycroft RJ. Contact allergy to methyldibromo glutaronitrile presenting as severe scalp seborrhoeic eczema. Contact Dermatitis 1999; 40: 335.
288. Pandya AG. Seborrhoeic dermatitis or tinea capitis: don't be fooled. Int J Dermatol 1998; 37: 827-8.
289. Weismann NK, Hjorth N, Fischer A. Zinc depletion syndrome with acrodermatitis enteropathica during long term intravenous feeding. Clin Exp Dermatol 1976; 1: 237-42.
290. Pierard-Franchimont C, Pierard GE, Arrese JE, De Doncker P. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology 2001; 202: 171-6.
291. Faergemann J, Jones TC, Hettler D, Loria Y. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options. Br J Dermatol 1996; 134 (Suppl. 46): 12-5.
292. Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole. Lancet 1984; ii: 1271-2.
293. Ford GP, Farr P, Ive FA, Shuster S. The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol 1984; 111: 603-7.
294. Green CA, Farr P, Shuster S. Treatment of seborrhoeic dermatitis with ketoconazole. II. Response of seborrhoeic dermatitis of face, scalp and trunk to topical ketoconazole. Br J Dermatol 1987; 116: 217-21.
295. Skinner RB. Double blind treatment of seborrhoeic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985; 12: 852-6.
296. Stratigos JD, Antoniou C, Katsambas A et al. Ketoconazole 2% cream versus hydrocortisone cream in the treatment of seborrhoeic dermatitis. J Am Acad Dermatol 1988; 19: 850-3.
297. Warshaw EM, Wohlhuter RJ, Liu A et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol 2007; 57: 257-64.
298. Meshkinpour A, Sun J, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 2003; 49: 145-7.
299. Parsad D, Pandhi R, Negi KS, Kumar B. Topical metronidazole in seborrhoeic dermatitis-a double blind study. Dermatology 2001; 202: 35-7.
300. Dupuy P, Maurette C, Amoric JC, Chosidow O. Study Investigator Group. Randomised placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis. Br J Dermatol 2001; 144: 1033-7.
301. Nakayama J. Four cases of sebopsoriasis or seborrhoeic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream. Eur J Dermatol 2000; 10: 528-32.
302. Bonnetblanc JM, Bernard P. Benzoyl peroxide in seborrhoeic dermatitis. Arch Dermatol 1986; 122: 752.
303. Boyle J, Burton JL, Faergemann J. Use of topical lithium succinate for seborrhoeic dermatitis. BMJ 1986; 292: 28.
304. Pirkhammer D, Seeber A, Honigsmann H, Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol 2000; 143: 964-8.
305. Scaparro E, Quadri G, Virno G et al. Evaluation of the efficacy and tolerability of oral terbinifine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomised, investigator-blinded, placebo-controlled trial. Br J Dermatol 2001; 144: 854-7.
306. Goodfield MJD, Saihan EM, Crowley J. Experimental folliculitis with Pityrosporum orbiculare: the influence of host response. Acta Derm Venereol (Stockh) 1987; 67: 445-7.
307. Hill MK, Goodfield MJ, Rodgers FG et al. Skin surface electron microscopy in Pityrosporum folliculitis. Arch Dermatol 1990; 126: 181-4.
308. Back O, Faergemann J. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol 1985; 12: 56-61.
309. Potter BS, Burgoon CF, Johnson WC. Pityrosporum folliculitis. Report of 7 cases and review of the Pityrosporum organism relative to cutaneous disease. Arch Dermatol 1973; 107: 388-91.
310. Kavanagh GM, Leeming JP, Marshman GM, Burton JL. Folliculitis in Down's syndrome. Br J Dermatol 1993; 129: 696-9.
311. Rhie S, Turcios R, Buckley H, Suh B. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart recipients. J Heart Lung Transplant 2000; 19: 215-9.
312. Yu HJ, Lee SK, Son SJ et al. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne. Int J Dermatol 1998; 37: 72-7.
313. Archer-Dubon C, Icaza-Chivez ME, Orozco-Topete R et al. An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: a previously unrecognised nosocomial infection. Int J Dermatol 1999; 38: 453-6.
314. Ford GP, Ive FA, Midgley G. Pityrosporum folliculitis and ketoconazole. Br J Dermatol 1982; 109: 691-5.
315. Faergemann J. Pityrosporum infections. J Am Acad Dermatol 1994; 31: s18-s20.
316. Burton JL. Venous hypertension, fibrin and leg ulcers. Br J Dermatol 1983; 109: 229-31.
317. Browse NL, Burnand KC. The cause of venous ulceration. Lancet 1982; ii: 243-5.
318. Coleridge Smith PD, Thomas P, Scurr JH et al. Causes of venous ulceration: a new hypothesis. BMJ 1988; 296: 1726-7.
319. Heng MC. The post-phlebitic syndrome. Int J Dermatol 1987; 26: 14-20.
320. Fontaine R. Remarks concerning venous thrombosis and its sequelae. Surgery 1957; 41: 6-25.
321. Piulachs P, Vidal-Barraquerr F. Pathogenic study of varicose veins. Angiology 1953; 4: 59-100.
322. Hopkins NFG. Positron emission tomography in venous ulceration and liposclerosis: a study of regional tissue function. BMJ 1983; 286: 333-6.
323. Thomas PRS, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. BMJ 1988; 296: 1693-5.
324. Peschen M, Lahaye T, Henning B et al. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency. Acta Derm Venereol (Stockh) 1999; 79: 27-32.
325. Bilen N, Apaydin R, Harova G et al. Stasis dermatitis of the hand associated with an iatrogenic arteriovenous fistula. Clin Exp Dermatol 1998; 23: 208-10.
326. Boyle J, Burton JL. Pseudo-Kaposi sarcoma. Lancet 1986; ii: 921.
327. Bahmer FZ. Immunohistologische Charakterisierung stauungsdermatotisch veränderter Unterschenkelhaut. Z Hautkr 1987; 62: 1056-63.
328. Fagrell B, Steirnstedt G, Ostergen J. Acrodermatitis chronica atrophicans (Herxheimer) can often mimic a peripheral vascular disorder. Acta Med Scand 1986; 220: 485-8.
329. Dissemond J, Knab J, Lehnen M et al. Successful treatment of stasis dermatitis with topical tacrolimus. Vasa 2004; 33: 260-2.
330. Cronin E. Contact dermatitis. VII: Reactions to contact allergens given orally and systemically. Br J Dermatol 1972; 86: 104-7.
331. de Groot AC, ed. Patch Testing. Test Concentrations and Vehicles for 2800 Allergens. Amsterdam: Elsevier, 1986.
332. Wilkinson DS. The role of contact allergy in hand eczema. Trans St John's Hosp Dermatol Soc 1970; 56: 19-27.
333. Bruynzeel DP, Maibach HI. Excited skin syndrome (angry back). Arch Dermatol 1986; 122: 323-8.
334. Hjorth N, Roed-Peterson J. Occupational protein contact dermatitis in food handlers. Contact Dermatitis 1976; 2: 28-42.
335. Samochocki Z, Owczarek W, Zabielski S. Can atopy patch tests with aeroallergens be an additional diagnostic criterion for atopic dermatitis? Eur J Dermatol 2006; 16: 151-4.
336. Ruzicka T, Bieber T, Schopf E et al. A short-term trial of tacrolimus ointment for atopic dermatitis. New Engl J Med 1997; 337: 816-21.
337. Nakagawa H. Phase III comparative study of FK506 ointment. Parallel-group comparison study with betamethasone valerate in atopic dermatitis of the trunk and limbs. Nishihinon J Dermatol 1997; 58: 870-9.
338. Reitamo S, Rustin M, Ruzicka T et al. Efficacy and safety of tacrolimus ointment compared with hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547-55.
339. Berth-Jones J, Damstra R, Golsch S et al. Fluticasone propionate (FP) reduces risk of relapse in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2000; 14 (Suppl. 1): 125.
340. Berth-Jones J, Graham-Brown RAC, Marks R et al. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol 1997; 136: 76-81.
341. Berth-Jones J, Takwale A, Tan E et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002; 147: 324-30.
342. George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrow-band (TL-01) UVB airconditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993; 128: 49-56.
343. Reynolds NJ, Franklin V, Gray JC. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 2001; 357: 2012-6.
344. Sheehen MP, Atherton DJ, Norris P, Hawk J. Oral psoralen photochemotherapy in severe childhood atopic eczema: an update. Br J Dermatol 1993; 129: 431-6.
345. Krutmann J, Czech W, Diepgen T et al. High dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-30.
346. Williams MG. Acanthomata appearing after eczema. Br J Dermatol 1956; 68: 268-71.
347. Horiuchi Y. Multiple seborrhoeic verrucae following eczema. J Dermatol 1989; 16: 505-7.
348. Robertson IM, Jordan JM, Whitlock FA. Emotions and skin (III)-the conditioning of scratch responses in cases of lichen simplex. Br J Dermatol 1975; 92: 407-12.
349. Singh G. Atopy in lichen simplex (neurodermatitis circumscripta). Br J Dermatol 1973; 88: 625-7.
350. Cormia FE. Basic concepts in the production and management of the psychosomatic dermatoses-II. Br J Dermatol 1951; 63: 129-51.
351. Cowan MA. Neurohistological changes in lichen simplex chronicus. Arch Dermatol 1964; 89: 562-8.
352. Shaffer B, Beerman H. Lichen simplex chronica and its variants. A discussion of certain psychodynamic mechanisms and clinical and histopathologic correlation. Arch Dermatol Syphilol 1951; 64: 340-51.
353. Marks R, Wells GC. Lichen simplex: morphodynamic correlates. Br J Dermatol 1973; 88: 249-56.
354. Marks R, Wells GC. A histochemical profile of lichen simplex. Br J Dermatol 1973; 88: 557-62.
355. Berlin C. Lichenificatio gigantea. (Lichenification géante of Brocq and Pautrier). Arch Dermatol Syphilol 1939; 39: 1012-20.
356. Kinsella LJ, Carney-Godley K, Feldman E. Lichen simplex chronicus as the initial manifestation of intramedullary neoplasm and syringomyelia. Neurosurgery 1992; 30: 418-21.
357. Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Arch Dermatol 1995; 131: 1403-8.
358. Tupker RA, Coenraads PJ, van der Meer JB. Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin. Acta Derm Venereol (Stockh) 1992; 72: 463.
359. Jackson R. The lines of Blaschko: a review and consideration. Observations of the cause of certain unusual linear conditions of the skin. Br J Dermatol 1976; 95: 349-60.
360. Toda K, Okamoto H, Horio T. Lichen striatus. Int J Dermatol 1986; 25: 584-5.
361. Reed RJ. Lichen striatus. A model for the histologic spectrum of lichenoid reactions. J Cutan Pathol 1975; 2: 1-18.
362. Staricco RG. Lichen striatus. Arch Dermatol 1959; 79: 311.
363. Stewart WM, Lauret P, Dietrini P. Lichen striatus: critères histologiques. Ann Dermatol Vénéréol 1977; 104: 132-5.
364. Charles CR. Lichen striatus. A clinical, histologic and electron microscopic study of an unusual case. J Cutan Pathol 1974; 1: 265-74.
365. Baran R, Dupré A, Lauret P et al. Le lichen striatus onychodystrophique. Ann Dermatol Vénéréol 1979; 106: 885-91.
366. Kaufman JP. Lichen striatus with nail involvement. Cutis 1974; 14: 232-4.
367. Rahbari H, Cordero AA, Mehregan AH. Linear porokeratosis. A distinctive clinic al variant of porokeratosis of Mibelli. Arch Dermatol 1974; 109: 526-8.
368. Wallengren J, Klinker M. Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study. J Am Acad Dermatol 1995; 32: 287-9.
369. Hebra F. On Diseases of the Skin. London: New Sydenham Society, 1868: 257.
370. Rowland-Payne CME. Prurigo nodularis. In: Bernhard J, ed. Itch: Mechanisms and Management of Pruritus. New York: McGraw Hill, 1994: 102-19.
371. Tanaka M, Aiba S, Matsumura N et al. Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset non-atopic. Dermatology 1995; 190: 269-76.
372. Rowland-Payne CME, Wilkinson JD, McKee PH. Nodular prurigo: a clinicopathological study of 46 patients. Br J Dermatol 1985; 113: 431-9.
373. Cowan MA. Neurohistological changes in prurigo nodularis. Arch Dermatol 1964; 89: 754-8.
374. Feuerman EJ, Sandbank M. Prurigo nodularis. Histological and microscopical study. Arch Dermatol 1975; 111: 1472-7.
375. Runne V, Orfanos EC. Cutaneous neural proliferation in highly pruritic lesions of chronic prurigo. Arch Dermatol 1977; 114: 787-91.
376. Perez GL, Peters MS, Reda AM et al. Mast cells, neutrophils and eosinophils in prurigo nodularis. Arch Dermatol 1993; 129: 861-6.
377. Doyle JA, Connolly SM, Hunziker N et al. Prurigo nodularis: a reappraisal of the clinical and histological features. J Cutan Pathol 1979; 6: 392-403.
378. Molina FA, Burrows NP, Russell Jones R et al. Increased sensory neuropeptides in nodular prurigo: a qualitative immunohistochemical study. Br J Dermatol 1992; 127: 344-51.
379. Vaalasti A, Suomalainen H, Rechardt L. Calcitonin-gene related peptide immunoreactivity in prurigo nodularis: a comparative study with neurodermatitis circumscripta. Br J Dermatol 1989; 120: 619-23.
380. Nahass GT, Penneys NS. Merkel cells and nodular prurigo. J Am Acad Dermatol 1994; 31: 86-8.
381. Bourke JF, Berth-Jones J, Gawkrodger DJ, Burns DA. Pemphigoid nodularis: a report of two cases. Clin Exp Dermatol 1994; 19: 496-9.
382. Massa MC, Connolly SM. Bullous pemphigoid with features of prurigo nodularis. Arch Dermatol 1982; 118: 937-9.
383. Ratnavel RC, Shranks AS, Grant JW, Norris PG. Juvenile pemphigoid nodularis. Br J Dermatol 1994; 130: 125-6.
384. Kang BD, Kye YC, Kim SN. Disseminated superficial actinic porokeratosis with both typical and prurigo nodularis-like lesions. J Dermatol 2001; 28: 81-5.
385. Zelickson BD, McEvoy MT, Fransway AF. Patch testing in prurigo nodularis. Contact Dermatitis 1989; 20: 321-5.
386. Murphy M, Carmichael AJ. Renal itch. Clin Exp Dermatol 2000; 25: 103-6.
387. Baykal C, Ozkaya-Bayazit E, Gokdemir G, Diz Kucukkaya R. The combined occurrence of macular amyloidosis and prurigo nodularis. Eur J Dermatol 2000; 10: 297-9.
388. Fina L, Grimalt R, Berti E. Nodular prurigo associated with Hodgkin's disease. Dermatologica 1991; 182: 243-6.
389. Matthews SN, Cockerell CJ. Prurigo nodularis in HIV-infected individuals. Int J Dermatol 1998; 37: 401-9.
390. McKenzie AW, Stubbing DG, Elvy BL. Prurigo nodularis and gluten enteropathy. Br J Dermatol 1976; 95: 89-92.
391. Wells GC. Skin disorders in relation to malabsorption. BMJ 1962; ii: 937-43.
392. Hudson PM, Black MM, Whimster IW. Nodular prurigo-a clinical, biochemical and histological study. Br J Dermatol 1978; 99 (Suppl. 16): 12.
393. Tupker RA, Coenraads PJ, van de Meer JB. Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin. Acta Derm Venereol (Stockh) 1992; 72: 463.
394. Yoshizawa Y, Kitamura K, Maibach HI. Successful immunotherapy of chronic nodular prurigo with topical dinitrochlorobenzene. Br J Dermatol 1999; 141: 387-9.
395. Van der Broek H. Treatment of prurigo nodularis with thalidomide. Arch Dermatol 1980; 116: 571-2.
396. Winkelmann RK. Thalidomide treatment of prurigo nodularis. Acta Derm Venereol (Stockh) 1984; 64: 412-7.
397. Berth-Jones J, Smith SG, Graham-Brown RAC. Nodular prurigo responds to cyclosporin. Br J Dermatol 1995; 132: 795-9.
398. Lear JT, English JSC, Smith AG. Nodular prurigo responsive to azathioprine. Br J Dermatol 1996; 134: 1151.
399. Ahmed E, McMillan MA. Cyclosporin treatment of nodular prurigo in a dialysis patient. Br J Dermatol 1997; 136: 805-6.
400. Vaatainen N, Hannuksela M, Karvonen J. Local photochemotherapy in nodular prurigo. Acta Derm Venereol (Stockh) 1979; 59: 544-7.
401. Hans SK, Cho MY, Park YK. UV treatment of generalised prurigo nodularis. J Am Acad Dermatol 1990; 29: 436-7.
402. Ferrandiz C, Carrasocsa JM, Just M et al. Sequential combined therapy with thalidomide and narrowband (TL01) UVB in the treatment of prurigo nodularis. Dermatology 1997; 195: 359-61.
403. Koblenzer CS. Treatment of nodular prurigo with cyclosporin (treat the disease, not just the symptoms). Br J Dermatol 1996; 135: 330-1.
404. Clark AR, Jorizzo JL, Fleischer AB. Papular dermatitis (subacute prurigo, 'itchy red bump' disease): Pilot study of phototherapy. J Am Acad Dermatol 1998; 38: 929-33.
405. Aso M, Miyamato T, Morimura T et al. Prurigo pigmentosa successfully treated with minocycline. Br J Dermatol 1989; 120: 705-8.
406. Cotterill JA, Ryatt KS, Greenwood R. Prurigo pigmentosa. Br J Dermatol 1981; 105: 707-10.
407. Cox NH. Prurigo pigmentosa. Br J Dermatol 1987; 117: 121-4.
408. Jorizzo J, Gath S, Smith EB. Prurigo-a clinical review. J Am Acad Dermatol 1981; 4: 723-9.
409. Joyce AP, Horn TD, Anholt GJ. Prurigo pigmentosa-review of the literature. Arch Dermatol 1989; 125: 1551-4.
410. Nagashima M. Prurigo pigmentosa-clinical observations in 14 cases. J Dermatol 1978; 5: 61-7.
411. Nakada T, Sueki H, Iijima M. Prurigo pigmentosa (Nagashima) associated with anorexia. Clin Exp Dermatol 1998; 23: 25-7.
412. Yazawa N, Ihn H, Yamane K et al. The successful treatment of prurigo pigmentosa with macrolide antibiotics. Dermatology 2001; 202: 67-9.
413. Nurse DS. Prurigo of pregnancy. Australas J Dermatol 1968; 9: 258-67.
414. Holmes RC, Black MM. The specific dermatoses of pregnancy. J Am Acad Dermatol 1983; 8: 405-12.
415. Sigurdsson V, Steegmans PHA, van Vloten WA. The incidence of erythroderma: a survey among all dermatologists in The Netherlands. J Am Acad Dermatol 2001; 45: 675-8.
416. Abrahams I, McCarthy JT, Sanders SL. 101 cases of exfoliative dermatitis. Arch Dermatol 1963; 87: 96-101.
417. Botella-Estrada R, Sanmartin O, Oliver V et al. Erythroderma: a clinico-pathological study of 56 cases. Arch Dermatol 1994; 130: 1503-7.
418. Hasan T, Jansen CT. Erythroderma: a follow-up of 50 cases. J Am Acad Dermatol 1983; 8: 836-40.
419. Rosen T, Chappell R, Drucker C. Exfoliative dermatitis: presenting sign of internal malignancy. South Med J 1979; 72: 652-3.
420. Nicolis GD, Helwig WB. Exfoliative dermatitis. A clinicopathological study of 135 cases. Arch Dermatol 1973; 108: 788-97.
421. Wong KS, Wong SN, Tham SN et al. Generalised exfoliative dermatitis: a clinical study of 108 patients. Ann Acad Med Singapore 1988; 17: 520-3.
422. Holme SA, Roberts DL. Erythroderma associated with St John's wort. Br J Dermatol 2000; 143: 1127-8.
423. Morrison JG. Sarcoidosis in a child presenting as erythroderma with keratotic spines. Br J Dermatol 1976; 95: 93-7.
424. Marsch WC, Stuttgen G. Generalized Hailey-Hailey disease. Br J Dermatol 1978; 99: 553.
425. Tappeiner G, Konrad K, Holubar K. Erythrodermic bullous pemphigoid. J Am Acad Dermatol 1982; 6: 489-92.
426. Bach M. Dermatological signs in the toxic shock syndrome. J Am Acad Dermatol 1983; 8: 343-7.
427. De Spain J, Clark DP. Subacute cutaneous lupus erythematosus presenting as erythroderma. J Am Acad Dermatol 1988; 19: 388-92.
428. Bernengo MG, Levi L, Zina G. Skin lesions in angio-immunoblastic lymphadenopathy. Br J Dermatol 1981; 104: 131-9.
429. Pierson JC, Taylor JS. Erythrodermic dermatomyositis. J Am Acad Dermatol 1993; 28: 136.
430. Sakakibara T, Ida T, Mannouji E et al. Post-transfusion graft-versus-host disease following open heart surgery: report of six cases. J Cardiovasc Surg 1989; 30: 687-91.
431. Janniger CK, Gascon P, Schwartz RA et al. Erythroderma as the initial presentation of the acquired immunodeficiency syndrome. Dermatologica 1991; 183: 143-5.
432. Sadick NS, McNutt NS, Kaplan MH. Papulosquamous dermatoses of AIDS. J Am Acad Dermatol 1990; 22: 1270-7.
433. Griffiths TW, Stevens SR, Cooper KD. Acute erythroderma as an exclusion criterion for idiopathic CD4??T lymphocytopenia. Arch Dermatol 1994; 130: 1530-3.
434. Walsh NMG, Prokopetz R, Tron VA et al. Histopathology in erythroderma: review of a series of cases by multiple observers. J Cutan Pathol 1994; 21: 419-23.
435. Sentis HJ, Willemze R, Scheffer E. Histopathologic studies of Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. J Am Acad Dermatol 1986; 15: 1217-26.
436. Abel EA, Lindae ML, Hoppe TR et al. Benign and malignant forms of cutaneous erythroderma: cutaneous immunophenotypic characteristics. J Am Acad Dermatol 1988; 19: 1089-95.
437. Asai T, Horiuchi Y. Senile erythroderma with serum hyper-IgE. Int J Dermatol 1989; 28: 225-8.
438. Boyd AS, Menter A. Erythrodermic psoriasis. J Am Acad Dermatol 1989; 21: 985-91.
439. Wilson DC, Jester JD, King LE. Erythroderma and exfoliative dermatitis. Clin Dermatol 1993; 11: 67-72.
440. King LE. Erythroderma. Who, where, when, why and how? Arch Dermatol 1994; 130: 1545-7.
441. King LE, Dufresne RG, Lovett G, Rosin MA. Erythroderma: review of 82 cases. South Med J 1986; 79: 1210-5.
442. Cherny S, Mraz S, Su L et al. Heteroduplex analysis of T-cell receptor gamma gene rearrangement as an adjuvant diagnostic tool in skin biopsies for erythroderma. J Cutan Pathol 2001; 28: 351-5.
443. Cordel N, Lenormand B, Courville P et al. Detection of clonal T-cell receptor gamma gene rearrangement with the use of PCR-DGGE for diagnosis of erythroderma. Ann Dermatol Venereol 2001; 128: 220-3.
444. Russell-Jones R, Whittaker S. T-cell receptor gene analysis in the diagnosis of Sézary syndrome. J Am Acad Dermatol 1999; 41: 254-9.
445. Thestrup-Pederson K, Halkier-Sorenson L, Sogaard H, Zacharie H. The red man syndrome: exfoliative dermatitis of unknown aetiology. A description and follow-up of 38 patients. J Am Acad Dermatol 1988; 18: 1307-12.
446. Shuster S, Wilkinson P. Protein metabolism in exfoliative dermatitis and erythroderma. Br J Dermatol 1963; 75: 344-53.
447. Studio Italiano Multicentrico Nella Psoriasi. Management of erythrodermic psoriasis with low-dose cyclosporin. Dermatology 1993; 187 (Suppl. 1): 30-7.
448. Zoon JJ, Mali JWH. The influence of erythroderma on the body. Arch Dermatol 1957; 75: 573-8.
449. Fox RH. Temperature regulation in erythroderma. J R Coll Physicians Lond 1967; 1: 372-9.
450. Leading Article. Haemodynamics of extensive skin disease. Lancet 1983; i: 1144.
451. Krook G. Hypothermia in patients with exfoliative dermatitis. Acta Derm Venereol (Stockh) 1960; 40: 142.
452. Freedberg IM, Baden HP. The metabolic response to exfoliation. J Invest Dermatol 1962; 38: 277-84.
453. Marks J, Shuster S. Method for measuring capillary permeability and its use in patients with skin disease. BMJ 1966; ii: 88-90.
454. Shuster S. Systemic effects of skin disease. J R Coll Physicians Lond 1967; 1: 345-55.
455. Worm AM, Taaning E, Rossing N. Distribution and degradation of albumin in extensive skin disease. Br J Dermatol 1981; 104: 389-96.
456. Frenk E, Guiessaz F, Vion B. Senile erythroderma with serum hyper-IgE. Dermatologica 1991; 183: 72-3.
457. Beuchner SA, Winkelmann RK. Pre-Sézary erythroderma evolving into Sézary syndrome. Arch Dermatol 1983; 119: 285-91.
458. Zip C, Murray S, Walsh NMG. The specificity of histopathology in erythroderma. J Cutan Pathol 1993; 20: 393-8.
459. Heng MCV. Erythroderma associated with mixed lymphoendothelial cell interactions and Staph. aureus infections. Br J Dermatol 1986; 115: 693-705.
460. Marsden JR. Cutaneous T-cell lymphomas. In: Lebwohl M, Heymann WR, Berth-Jones J, Coulson I, eds. Treatment of Skin Disease: Comprehensive Therapeutic Strategies. London: Mosby, 2002: 131-7.
461. Zackheim HS, Kashani-Sabet M, Hwang ST. Low dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in 29 patients. J Am Acad Dermatol 1996; 34: 626-31.
462. Heald P, Rook A, Perez M et al. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992; 27: 427-33.
463. Ofuji S, Furukawa F, Miyachi Y et al. Papuloerythroderma. Dermatologica 1984; 16: 125-30.
464. Bech-Thomsen N, Thomsen K. Ofuji's papuloerythroderma: a study of 17 cases. Clin Exp Dermatol 1998; 23: 79-83.
465. Farthing CF, Staughton RCD, Harper JI et al. Dermatologica 1986; 172: 65-6.
466. Grobb JJ, Collet-Villette AM, Horchowski N et al. Ofuji papuloerythroderma. Report of a case with T-cell skin lymphoma and discussion of the nature of this disease. J Am Acad Dermatol 1989; 20: 927-31.
467. Ofuji S. Papuloerythroderma. J Am Acad Dermatol 1990; 22: 697.
468. Schepers C, Malvehy J, Azon-Masoliver A et al. Papuloerythroderma of Ofuji: a report of two cases including the first European case associated with visceral carcinoma. Dermatology 1996; 193: 131-5.
469. Nishijima S. Papuloerythroderma associated with hepatocellular carcinoma. Br J Dermatol 1998; 139: 1115-6.
470. Dwer CM, Chapman RS, Smith GD. Papuloerythroderma and cutaneous T-cell lymphoma. Dermatology 1994; 188: 326-8.
471. Shah M, Reid WA, Layton AM. Cutaneous T-cell lymphoma presenting as papuloerythroderma-a case and review of the literature. Clin Exp Dermatol 1995; 20: 161-3.
472. Tan YK, Tan KC, Ong BH. Papuloerythroderma of Ofuji and cutaneous T-cell lymphoma. Br J Dermatol 1997; 137: 160-1.
473. Garcia-Patos V, Repiso T, Rodriguez-Cano L, Castells A. Ofuji papuloerythroderma in a patient with the acquired immunodeficiency syndrome. Dermatology 1996; 192: 164-6.
474. Lonnee ER, Toonstra J, van der Putte SCJ et al. Papuloerythroderma of Ofuji in a HIV-infected patient. Br J Dermatol 1996; 135: 489-504.
475. Azon-Masoliver A, Casado J, Brunet J et al. Ofuji's papuloerythroderma following choledocholithiasis with secondary sepsis: complete resolution with surgery. Clin Exp Dermatol 1998: 23: 84-6.
476. Quemeneur T, Ghislain PD, Morant C et al. Ofuji's papuloerythroderma: two cases treated with azathioprine. Ann Dermatol Venereol 2002; 129: 213-5.
477. Sommer S, Henderson CA. Papuloerythroderma of Ofuji responding to treatment with cyclosporin. Clin Exp Dermatol 2000; 25: 293-5.
478. Fujii K, Kanno Y, Ohgo N. Etretinate therapy for papuloerythroderma. Eur J Dermatol 1999; 9: 610-3.